Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study (Q44695861)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study |
scientific article published in January 2004 |
Statements
1 reference
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study (English)
1 reference
1 reference
C Pico
1 reference
M Martin
1 reference
C Jara
1 reference
A Barnadas
1 reference
A Pelegri
1 reference
A Balil
1 reference
A Frau
1 reference
A Rodriguez-Lescure
1 reference
J M Lopez-Vega
1 reference
J De La Haba
1 reference
A Tres
1 reference
I Alvarez
1 reference
E Alba
1 reference
A Arcusa
1 reference
A Oltra
1 reference
N Batista
1 reference
T Checa
1 reference
R Perez-Carrion
1 reference
J Curto
1 reference
GEICAM Group
1 reference
1 January 2004
1 reference
1 reference
15
1 reference
1
1 reference
79-87
1 reference
Identifiers
1 reference
1 reference